[
  {
    "ts": null,
    "headline": "Merck & Co. Inc. stock underperforms Monday when compared to competitors",
    "summary": "Merck & Co. Inc. stock underperforms Monday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=c0dc3ee8ee07d224eb1334b68f40efb54e85178c2b118389296ccf0131d364aa",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733157300,
      "headline": "Merck & Co. Inc. stock underperforms Monday when compared to competitors",
      "id": 131775680,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Merck & Co. Inc. stock underperforms Monday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=c0dc3ee8ee07d224eb1334b68f40efb54e85178c2b118389296ccf0131d364aa"
    }
  },
  {
    "ts": null,
    "headline": "Summit Therapeutics Stock Set To Soar By Mid-2025 On HARMONi Phase 3 Trial",
    "summary": "Summit Therapeutics Stock Set To Soar By Mid-2025 On HARMONi Phase 3 Trial",
    "url": "https://finnhub.io/api/news?id=b1533c5d58e2babb503cb211aab91b9ff1c2847d558dd8bbc4353b8584c0bda4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733148607,
      "headline": "Summit Therapeutics Stock Set To Soar By Mid-2025 On HARMONi Phase 3 Trial",
      "id": 131741136,
      "image": "",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=b1533c5d58e2babb503cb211aab91b9ff1c2847d558dd8bbc4353b8584c0bda4"
    }
  },
  {
    "ts": null,
    "headline": "TCW Relative Value Large Cap Fund Q3 2024 Commentary",
    "summary": "TCW Relative Value Large Cap Fund portfolioâs top 10 average-weighted names returned 12.9%, on average, better than the portfolio and benchmark index led by robust gains from IBM.",
    "url": "https://finnhub.io/api/news?id=8d94b32f6adb1e80dc6745e03ccf32cd6b275b1561664313264bbba5987de7ac",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733143380,
      "headline": "TCW Relative Value Large Cap Fund Q3 2024 Commentary",
      "id": 131739962,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2158301126/image_2158301126.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "TCW Relative Value Large Cap Fund portfolioâs top 10 average-weighted names returned 12.9%, on average, better than the portfolio and benchmark index led by robust gains from IBM.",
      "url": "https://finnhub.io/api/news?id=8d94b32f6adb1e80dc6745e03ccf32cd6b275b1561664313264bbba5987de7ac"
    }
  },
  {
    "ts": null,
    "headline": "Why Is Merck & Co., Inc. (MRK) Among the Stocks Ray Dalio’s Bridgewater Is Crazy About?",
    "summary": "We recently compiled a list of the Billionaire Ray Dalio’s Bridgewater Is Crazy About These 15 Stocks. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other stocks Ray Dalio’s Bridgewater is crazy about. Ray Dalio, a seasoned global macro investor with over 50 years […]",
    "url": "https://finnhub.io/api/news?id=022bd8dc86c54f9cd6881537258230d46cdc0261e9fe03f9c0c0013b53744312",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733141587,
      "headline": "Why Is Merck & Co., Inc. (MRK) Among the Stocks Ray Dalio’s Bridgewater Is Crazy About?",
      "id": 131738400,
      "image": "https://s.yimg.com/ny/api/res/1.2/krpa0cobX2AdeFb7DJ59pg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/3c1e6d485df373db04a8fd19fdaf6c3a",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the Billionaire Ray Dalio’s Bridgewater Is Crazy About These 15 Stocks. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other stocks Ray Dalio’s Bridgewater is crazy about. Ray Dalio, a seasoned global macro investor with over 50 years […]",
      "url": "https://finnhub.io/api/news?id=022bd8dc86c54f9cd6881537258230d46cdc0261e9fe03f9c0c0013b53744312"
    }
  },
  {
    "ts": null,
    "headline": "Tracking Ray Dalio's Bridgewater Associates 13F Portfolio - Q3 2024 Update",
    "summary": "Bridgewater Associates' 13F portfolio decreased to ~$17.66B. Read more to see the portfolio's Q3, 2024 update.",
    "url": "https://finnhub.io/api/news?id=05a13c4ff9c275f61946095101d3ec8a2bf74842725f5122607d8596b0d137d2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733111195,
      "headline": "Tracking Ray Dalio's Bridgewater Associates 13F Portfolio - Q3 2024 Update",
      "id": 131735363,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1333504671/image_1333504671.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Bridgewater Associates' 13F portfolio decreased to ~$17.66B. Read more to see the portfolio's Q3, 2024 update.",
      "url": "https://finnhub.io/api/news?id=05a13c4ff9c275f61946095101d3ec8a2bf74842725f5122607d8596b0d137d2"
    }
  }
]